DOW JONES25,409.36-357.28 -1.39%
S&P 5002,954.22-24.54 -0.82%
NASDAQ8,567.37+0.89 0.01%

Morgan Stanley Maintains Overweight on Regenxbio, Raises Price Target to $58

Morgan Stanley maintains Regenxbio (NASDAQ:RGNX) with a Overweight and raises the price target from $55 to $58.

Benzinga · 01/17/2020 13:30

Morgan Stanley maintains Regenxbio (NASDAQ:RGNX) with a Overweight and raises the price target from $55 to $58.